Article Menu
Need Help?
No Article Versions Notes Found
Cite
Zhou, J.; Millier, A.; François, C.; Aballéa, S.; Toumi, M. Systematic Review of Utility Values Used in the Pharmacoeconomic Evaluations for Schizophrenia: Implications on Cost-Effectiveness Results. J. Mark. Access Health Policy 2019, 7, 1648973. https://doi.org/10.1080/20016689.2019.1648973
Zhou J, Millier A, François C, Aballéa S, Toumi M. Systematic Review of Utility Values Used in the Pharmacoeconomic Evaluations for Schizophrenia: Implications on Cost-Effectiveness Results. Journal of Market Access & Health Policy. 2019; 7(1):1648973. https://doi.org/10.1080/20016689.2019.1648973
Chicago/Turabian StyleZhou, Junwen, Aurélie Millier, Clément François, Samuel Aballéa, and Mondher Toumi. 2019. "Systematic Review of Utility Values Used in the Pharmacoeconomic Evaluations for Schizophrenia: Implications on Cost-Effectiveness Results" Journal of Market Access & Health Policy 7, no. 1: 1648973. https://doi.org/10.1080/20016689.2019.1648973
APA StyleZhou, J., Millier, A., François, C., Aballéa, S., & Toumi, M. (2019). Systematic Review of Utility Values Used in the Pharmacoeconomic Evaluations for Schizophrenia: Implications on Cost-Effectiveness Results. Journal of Market Access & Health Policy, 7(1), 1648973. https://doi.org/10.1080/20016689.2019.1648973
